A citation-based method for searching scientific literature

Efficacy of Combination Chemo-Immunotherapy as a First-Line Treatment for Advanced Non-Small-Cell Lung Cancer Patients With HER2 Alterations: A Case Series.
Shuang Zhao, Xinghong Xian, Panwen Tian, Weimin Li, Ke Wang, Yalun Li. Front Oncol 2021
Times Cited: 1



Lung adenocarcinoma harboring mutations in the ERBB2 kinase domain.
Makoto Sonobe, Toshiaki Manabe, Hiromi Wada, Fumihiro Tanaka. J Mol Diagn 2006
Times Cited: 32




List of shared articles



Times cited

Treatment efficacy of HER2-mutant lung adenocarcinoma by immune checkpoint inhibitors: a multicenter retrospective study.
Xiangling Chu, Huiping Qiang, Mengqing Xie, Xing Li, Jing Zhao, Yan Wu, Juan Zhou, Jinyan Ye, Chao Zhao, Chaonan Han,[...]. Cancer Immunol Immunother 2021
1


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy